A61P 15/12
Drugs for genital or sexual disorders: for climacteric disorders
Official title: for climacteric disorders
A61P15/12 (Drugs for genital or sexual disorders: for climacteric disorders) appears on 955 US grants and 1,533 published applications in this corpus.
Search patents in A61P- Granted patents
- 955
- Published applications
- 1,533
- Assignees
- 558
- Inventors
- 2,624
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 13 | 0 |
| 1997 | 1 | 0 |
| 1998 | 18 | 0 |
| 1999 | 18 | 0 |
| 2000 | 17 | 0 |
| 2001 | 18 | 13 |
| 2002 | 32 | 53 |
| 2003 | 28 | 79 |
| 2004 | 33 | 101 |
| 2005 | 25 | 115 |
| 2006 | 40 | 93 |
| 2007 | 34 | 96 |
| 2008 | 43 | 95 |
| 2009 | 51 | 108 |
| 2010 | 61 | 114 |
| 2011 | 48 | 91 |
| 2012 | 65 | 88 |
| 2013 | 51 | 71 |
| 2014 | 60 | 73 |
| 2015 | 68 | 63 |
| 2016 | 39 | 35 |
| 2017 | 37 | 32 |
| 2018 | 29 | 30 |
| 2019 | 20 | 33 |
| 2020 | 28 | 26 |
| 2021 | 21 | 29 |
| 2022 | 14 | 20 |
| 2023 | 11 | 23 |
| 2024 | 11 | 20 |
| 2025 | 11 | 17 |
| 2026 | 3 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oral composition for perimenopause14 Jul 2026US 12,678,452 B2Huntgreenliving LLC
- Combination drug therapies for CNS disorders10 Feb 2026US 12,544,385 B2
- Methods of treatment with elinzanetant27 Jan 2026US 12,533,358 B1Bayer Consumer Care AG
- Compounds and their uses for alleviating menopause-associated symptoms4 Nov 2025US 12,458,651 B2Estetra Srl
- Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause14 Oct 2025US 12,440,522 B2Solarea Bio, Inc.
- Ketamine for the treatment of menstrually related symptoms1 Oct 2026US 2026/0294843 A1
- Dissolvable microneedle patch for large molecule therapeutic delivery17 Sep 2026US 2026/0273253 A1Maman Biomedical Inc.
- Compositions for treating a subject from sexual dysfunction27 Aug 2026US 2026/0248810 A1
- Methods and devices for hormone replacement therapy30 Jul 2026US 2026/0216062 A1
- Use of estetrol in hepatically impaired patients23 Jul 2026US 2026/0207623 A1Estetra Srl
Most cited
By later US patents
- Transdermal drug delivery matrix for coadministering estradiol and another steroid110US 5,783,208 ATheratech, Inc. · 1998
- Benzothiophene compounds intermediate compositions and methods for inhibiting aortal smooth muscle proliferation98US 5,492,922 AEli Lilly and Company · 1996
- Organic compounds95US 8,664,207 B2Intra-Cellular Therapies, Inc. · 2014
- Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents94US 7,157,491 B2Wyeth · 2007
- Optionally substituted 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo [3,4-d]pyrimidin-6(7H)-ones94US 8,697,710 B2Intra-Cellular Therapies, Inc. · 2014